<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04788056</url>
  </required_header>
  <id_info>
    <org_study_id>2021P000486</org_study_id>
    <nct_id>NCT04788056</nct_id>
  </id_info>
  <brief_title>Parasternal Subpectoral Plane Blocks for Cardiac Surgery Via a Midline Sternotomy</brief_title>
  <official_title>Parasternal Subpectoral Plane Blocks for Patients Undergoing Cardiac Surgery Involving Median Sternotomy - a Study of Opioid and Pain Reduction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To better determine whether parasternal subpectoral plane blocks (PSPB) infusing bupivacaine&#xD;
      for midline sternotomy decreases opioid consumption and pain scores.&#xD;
&#xD;
      This is a prospective, blinded randomized controlled trial with 2 arms. 1 arm is the saline&#xD;
      control arm, PSPB catheters will be placed with saline and continue to infuse saline. The&#xD;
      other arm is bupivacaine study arm, PSPB catheters will be placed with bupivacaine and&#xD;
      continue to infuse the local anesthetic.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will be randomized to receive PSPB catheters infusing either bupivacaine or saline.&#xD;
      Randomization will be achieved using a computer-generated randomization scheme. The surgeon,&#xD;
      nurse, anesthetist and patient will be blinded. The investigational drug service will prepare&#xD;
      blinded solutions (bupivacaine 0.2% or saline syringes) for performance of the block. They&#xD;
      will also prepare bags (either bupivacaine 0.125% or saline) to be infused through the&#xD;
      catheter.&#xD;
&#xD;
      Following skin closure, but before removal of the surgical drapes, regional anesthesiologists&#xD;
      will scrub in, gown and perform the placement of PSPB catheters under strict surgical aseptic&#xD;
      technique. Real-time ultrasound (US) imaging will be used to visualize the pectoralis major&#xD;
      muscle and its corresponding rib cartilages, and a needle/introducer sheath will be guided&#xD;
      parasternally into the fascial plane. The needle will be advanced in the plane,&#xD;
      hydro-dissecting with 30 mL of bupivacaine 0.2% in the study group or 30 mL of saline in the&#xD;
      control group per side. Following hydro-dissection, a 5 in. multiport catheter will be&#xD;
      inserted via the sheath, and the catheter will be secured following US confirmation of&#xD;
      appropriate catheter position. This procedure will then be repeated on the other side. After&#xD;
      completion of bilateral PSPB catheters, patients will remain intubated and be transferred to&#xD;
      the CSICU on a sedation regimen at the discretion of the intraoperative anesthesia team. Upon&#xD;
      dropping off to the ICU, each catheter will be attached to a programmable pump infusing plain&#xD;
      bupivacaine 0.125% at 10 mL/hr or saline infusing at 10 mL/hr. Once again, the solution to be&#xD;
      infused postoperatively will be prepared by pharmacy and blinded from the patient, nurse, and&#xD;
      postoperative pain service providers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2021</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Saline and Bupivacaine are both clear fluids and look identical. Research pharmacy will prepare blinded solutions for use in study.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>2 days</time_frame>
    <description>Cumulative opioid consumption on post-operative day 1 and 2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute Postoperative Pain scores</measure>
    <time_frame>through initial hospital stay, an average of 5 days</time_frame>
    <description>At rest and activity, on a numerical rating scale (NRS) 0-10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Postoperative Pain scores</measure>
    <time_frame>Measured at 1 year</time_frame>
    <description>Persistent midline sternotomy pain, on a numerical rating scale (NRS) 0-10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain and patient characteristics</measure>
    <time_frame>1 year</time_frame>
    <description>Whether there is a correlation between development of persistent post-sternotomy pain and psychosocial/psychophysical characteristics. Will be ascertained from a variety of questionnaires (i.e. brief pain index, brief symptom inventory, coping strategies, fibromyalgianess, pain catastrophizing scale, positive and negative affect scale, PROMIS anxiety short form (SF), PROMIS depression SF, PROMIS sleep disturbance SF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of arrhythmia</measure>
    <time_frame>Hospital stay, an average of 5 days</time_frame>
    <description>Whether active bupivacaine group has lower incidence of arrythmia versus saline control group. And whether this correlates to a certain plasma bupivacine level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to extubation</measure>
    <time_frame>Post-operative day 1</time_frame>
    <description>From arrival time to ICU to extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>From arrival to ICU to discharge to floor, up to 5 days</time_frame>
    <description>When patients are deemed ready to be discharged from ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>From arrival to ICU to discharge from hospital, up to 5 days</time_frame>
    <description>When patients are deemed ready to be discharged from hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of delirium</measure>
    <time_frame>Time in ICU to discharge to floor, up to 3 days</time_frame>
    <description>Assessed using CAM-ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first opioid administration after extubation</measure>
    <time_frame>Extubation to first opioid administration, up to 3 days</time_frame>
    <description>When patient first requests opioid after extubation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">154</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PSPB catheters will be placed with 60mL of 0.2% bupivacaine and continue to infuse bupivacaine 0.125% at 10mL/hr through the catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>PSPB catheters will be placed with 60mL of saline and continue to infuse saline through the catheters.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Parasternal Subpectoral Plane Block</intervention_name>
    <description>Nerve block catheter inserted into plane between rib cartilages and pectoralis muscle.</description>
    <arm_group_label>Bupivacaine</arm_group_label>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or Female&#xD;
&#xD;
          2. Aged 18 - 80 years&#xD;
&#xD;
          3. scheduled for primary elective cardiac surgery via median sternotomy&#xD;
&#xD;
          4. willingness to undergo psychosocial testing&#xD;
&#xD;
          5. willingness to participate in long-term follow up&#xD;
&#xD;
          6. willingness to be randomized to receive local anesthetic or saline infusion through&#xD;
             PSPB catheters&#xD;
&#xD;
          7. access to an email and computer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Allergy to opioids&#xD;
&#xD;
          2. allergy to bupivacaine&#xD;
&#xD;
          3. emergency surgery&#xD;
&#xD;
          4. unable to provide informed consent&#xD;
&#xD;
          5. weight less than 50kg&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kamen Vlassakov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kamen Vlassakov, MD</last_name>
    <phone>6177328221</phone>
    <email>kvlassakov@bwh.harvard.edu</email>
  </overall_contact>
  <reference>
    <citation>Lahtinen P, Kokki H, Hynynen M. Pain after cardiac surgery: a prospective cohort study of 1-year incidence and intensity. Anesthesiology. 2006 Oct;105(4):794-800.</citation>
    <PMID>17006079</PMID>
  </reference>
  <reference>
    <citation>Huang AP, Sakata RK. Pain after sternotomy - review. Braz J Anesthesiol. 2016 Jul-Aug;66(4):395-401. doi: 10.1016/j.bjane.2014.09.013. Epub 2016 Apr 23. Review.</citation>
    <PMID>27343790</PMID>
  </reference>
  <reference>
    <citation>Edwards RR, Cahalan C, Mensing G, Smith M, Haythornthwaite JA. Pain, catastrophizing, and depression in the rheumatic diseases. Nat Rev Rheumatol. 2011 Apr;7(4):216-24. doi: 10.1038/nrrheum.2011.2. Epub 2011 Feb 1. Review. Erratum in: Nat Rev Rheumatol.. Correction on page following 224.. Nat Rev Rheumatol. 2011 Jun;7(6):314. Calahan, Christine [corrected to Cahalan, Christine].</citation>
    <PMID>21283147</PMID>
  </reference>
  <reference>
    <citation>Taillefer MC, Carrier M, Bélisle S, Levesque S, Lanctôt H, Boisvert AM, Choinière M. Prevalence, characteristics, and predictors of chronic nonanginal postoperative pain after a cardiac operation: a cross-sectional study. J Thorac Cardiovasc Surg. 2006 Jun;131(6):1274-80.</citation>
    <PMID>16733157</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 26, 2021</study_first_submitted>
  <study_first_submitted_qc>March 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2021</study_first_posted>
  <last_update_submitted>March 4, 2021</last_update_submitted>
  <last_update_submitted_qc>March 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Kamen Vlassakov</investigator_full_name>
    <investigator_title>Director of Regional Anesthesia</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

